Related Experiment Videos
[Problems of prophylaxis and treatment of infectious complications in reconstructive surgery]
Abstract:
Infectious complications due to polyresistant staphylococci as well as strepto- and enterococci are of serious problem in reconstructive surgery, since the number of such strains isolated within 1999-2004 has amounted to 58.4-59.7% of all the isolates. Susceptibility testing of 195 isolates showed that 100% of them was susceptible to linezolid that was used in the postoperative treatment of 28 patients after reconstructive surgical operations including those with artificial circulation under conditions of a multiprofile surgical hospital. Linezolid proved to be a highly effective agent in the prophylaxis and treatment of infectious complications due to polyresistant grampositive pathogens. Step-by-step therapy with linezolid was shown possible. In the treatment of pediatric cases no side effects of linezolid were recorded.
Insights
Polyresistant gram-positive bacteria pose a significant challenge in reconstructive surgery. Linezolid demonstrated 100% effectiveness against these pathogens in a study, proving safe for pediatric use.
Area of Science:
- Infectious Diseases
- Surgical Infections
- Antimicrobial Resistance
Background:
- Polyresistant staphylococci, streptococci, and enterococci are a major cause of infectious complications in reconstructive surgery.
- These resistant strains constituted 58.4-59.7% of isolates between 1999-2004, highlighting a growing clinical problem.
Purpose of the Study:
- To evaluate the efficacy and safety of linezolid in treating and preventing infectious complications caused by polyresistant gram-positive pathogens in reconstructive surgery patients.
- To assess the potential for step-by-step therapy with linezolid in this patient population.
Main Methods:
- Susceptibility testing was performed on 195 clinical isolates.
- Linezolid was administered to 28 patients undergoing reconstructive surgery, including those requiring artificial circulation.
- Clinical outcomes and side effects, particularly in pediatric cases, were monitored.
Main Results:
- All tested isolates (100%) were susceptible to linezolid.
- Linezolid proved highly effective in both prophylaxis and treatment of infections caused by polyresistant gram-positive pathogens.
- No adverse side effects were observed in pediatric patients treated with linezolid.
Conclusions:
- Linezolid is a highly effective therapeutic option for managing infectious complications stemming from polyresistant gram-positive bacteria in reconstructive surgery.
- Step-by-step treatment protocols utilizing linezolid are feasible.
- Linezolid exhibits a favorable safety profile, even in pediatric populations.
Related Concept Videos
Healing II: Complications
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Endocarditis III: Medical Management
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...